Home > Research > Publications & Outputs > Relapsing cerebral amyloid angiopathy-related i...

Research

Links

Text available via DOI:

Keywords

View graph of relations

Relapsing cerebral amyloid angiopathy-related inflammation: the wax and the wane

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Published

Standard

Relapsing cerebral amyloid angiopathy-related inflammation: the wax and the wane. / Salam, Sharfaraz; Anandarajah, Mayooreshan; Al-Bachari, Sarah et al.
In: Practical Neurology, Vol. 17, No. 5, 10.2017, p. 392-395.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Harvard

Salam, S, Anandarajah, M, Al-Bachari, S, Pal, P, Sussman, J & Hamdalla, H 2017, 'Relapsing cerebral amyloid angiopathy-related inflammation: the wax and the wane', Practical Neurology, vol. 17, no. 5, pp. 392-395. https://doi.org/10.1136/practneurol-2017-001599

APA

Salam, S., Anandarajah, M., Al-Bachari, S., Pal, P., Sussman, J., & Hamdalla, H. (2017). Relapsing cerebral amyloid angiopathy-related inflammation: the wax and the wane. Practical Neurology, 17(5), 392-395. https://doi.org/10.1136/practneurol-2017-001599

Vancouver

Salam S, Anandarajah M, Al-Bachari S, Pal P, Sussman J, Hamdalla H. Relapsing cerebral amyloid angiopathy-related inflammation: the wax and the wane. Practical Neurology. 2017 Oct;17(5):392-395. Epub 2017 Jun 24. doi: 10.1136/practneurol-2017-001599

Author

Salam, Sharfaraz ; Anandarajah, Mayooreshan ; Al-Bachari, Sarah et al. / Relapsing cerebral amyloid angiopathy-related inflammation : the wax and the wane. In: Practical Neurology. 2017 ; Vol. 17, No. 5. pp. 392-395.

Bibtex

@article{ea1b0dc481f649bd8fee05b5ba3384ff,
title = "Relapsing cerebral amyloid angiopathy-related inflammation: the wax and the wane",
abstract = "Cerebral amyloid angiopathy-related inflammation (CAA-I) is a rare variant of cerebral amyloid angiopathy (CAA). Its precise pathophysiology remains uncertain and we currently have limited evidence on which immunosuppressive agents are the most effective in its treatment. The disease course of CAA-I disorders can vary from an isolated clinical event to recurrent episodes. We present a case of biopsy-confirmed CAA-I that gives insight into its potential relapsing nature and the challenges of its long-term management.",
keywords = "Amyloid beta-Peptides, Brain, Cerebral Amyloid Angiopathy, Disease Progression, Encephalitis, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Case Reports, Journal Article",
author = "Sharfaraz Salam and Mayooreshan Anandarajah and Sarah Al-Bachari and Piyali Pal and Jonathan Sussman and Hisham Hamdalla",
note = "{\textcopyright} Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.",
year = "2017",
month = oct,
doi = "10.1136/practneurol-2017-001599",
language = "English",
volume = "17",
pages = "392--395",
journal = "Practical Neurology",
issn = "1474-7758",
publisher = "BMJ Publishing Group",
number = "5",

}

RIS

TY - JOUR

T1 - Relapsing cerebral amyloid angiopathy-related inflammation

T2 - the wax and the wane

AU - Salam, Sharfaraz

AU - Anandarajah, Mayooreshan

AU - Al-Bachari, Sarah

AU - Pal, Piyali

AU - Sussman, Jonathan

AU - Hamdalla, Hisham

N1 - © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

PY - 2017/10

Y1 - 2017/10

N2 - Cerebral amyloid angiopathy-related inflammation (CAA-I) is a rare variant of cerebral amyloid angiopathy (CAA). Its precise pathophysiology remains uncertain and we currently have limited evidence on which immunosuppressive agents are the most effective in its treatment. The disease course of CAA-I disorders can vary from an isolated clinical event to recurrent episodes. We present a case of biopsy-confirmed CAA-I that gives insight into its potential relapsing nature and the challenges of its long-term management.

AB - Cerebral amyloid angiopathy-related inflammation (CAA-I) is a rare variant of cerebral amyloid angiopathy (CAA). Its precise pathophysiology remains uncertain and we currently have limited evidence on which immunosuppressive agents are the most effective in its treatment. The disease course of CAA-I disorders can vary from an isolated clinical event to recurrent episodes. We present a case of biopsy-confirmed CAA-I that gives insight into its potential relapsing nature and the challenges of its long-term management.

KW - Amyloid beta-Peptides

KW - Brain

KW - Cerebral Amyloid Angiopathy

KW - Disease Progression

KW - Encephalitis

KW - Humans

KW - Magnetic Resonance Imaging

KW - Male

KW - Middle Aged

KW - Case Reports

KW - Journal Article

U2 - 10.1136/practneurol-2017-001599

DO - 10.1136/practneurol-2017-001599

M3 - Journal article

C2 - 28647708

VL - 17

SP - 392

EP - 395

JO - Practical Neurology

JF - Practical Neurology

SN - 1474-7758

IS - 5

ER -